Literature DB >> 12959278

Interindividual variability of phenol- and catechol-sulphotransferases in platelets from adults and newborns.

G M Pacifici1, G Marchi.   

Abstract

1 Phenol- and catechol- sulphotransferase activities were measured with p-nitrophenol and dopamine as substrates in platelets obtained from 100 newborns and 100 healthy adults. 2 Mean +/- (s.d.) estimates of catechol sulphotransferase activity were 7.07 +/- 5.93 (adult) and 13.3 +/- 6.42 (newborn) pmol min(-1) mg(-1) protein, respectively (P < 0.001). The coefficients of variation were 84% (adult) and 48% (newborn). The frequency distribution of sulphotransferase activity was symmetric and did not deviate significantly from normality in newborn platelets, but was positively skewed in adult platelets. 3 Mean +/- (s.d.) estimates of phenol sulphotransferase activity were 3.01 +/- 3.21 (adult) and 4.80 +/- 4.34 (newborn) pmol min(-1) mg(-1), respectively (P < 0.001). The coefficients of variation were 107% (adult) and 90% (newborn). The frequency distribution of sulphotransferase activity was positively skewed in both newborn and adult platelets. 4 Since sulphotransferase activity in platelets is well-expressed at birth and a prenatal development of sulphotransferase has been described in mid-gestational human foetal liver, the newborn should be able to sulphate drugs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 12959278      PMCID: PMC1364666          DOI: 10.1111/j.1365-2125.1993.tb00420.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  31 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Rat brain phenolsulfotransferase: partial purification and some properties.

Authors:  A Foldes; J L Meek
Journal:  Biochim Biophys Acta       Date:  1973-12-19

3.  Platelet phenol sulfotransferase activity: correlation with sulfate conjugation of acetaminophen.

Authors:  C Reiter; R Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  1982-11       Impact factor: 6.875

4.  Multiple forms of phenolsulphotransferase in human tissues: selective inhibition by dichloronitrophenol.

Authors:  G Rein; V Glover; M Sandler
Journal:  Biochem Pharmacol       Date:  1982-05-15       Impact factor: 5.858

5.  Platelet phenolsulphotransferase deficiency in dietary migraine.

Authors:  J Littlewood; V Glover; M Sandler; R Petty; R Peatfield; F C Rose
Journal:  Lancet       Date:  1982-05-01       Impact factor: 79.321

6.  Human platelet phenol sulfotransferase: partial purification and detection of two forms of the enzyme.

Authors:  P R Butler; R J Anderson; D L Venton
Journal:  J Neurochem       Date:  1983-09       Impact factor: 5.372

7.  Human platelet phenolsulphotransferase M and P: substrate specificities and correlation with in vivo sulphoconjugation of paracetamol and salicylamide.

Authors:  S M Bonham Carter; G Rein; V Glover; M Sandler; J Caldwell
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

8.  Sulphate conjugation of biologically active monoamines and their metabolites by human platelet phenolsulphotransferase.

Authors:  G Rein; V Glover; M Sandler
Journal:  Clin Chim Acta       Date:  1981-04-09       Impact factor: 3.786

9.  Platelet phenolsulfotransferase and catecholamines: physiological and pathological variations in humans.

Authors:  L Abenhaim; Y Romain; O Kuchel
Journal:  Can J Physiol Pharmacol       Date:  1981-03       Impact factor: 2.273

10.  Human platelet phenolsulphotransferase: separate control of the two forms and activity range in depressive illness.

Authors:  S M Carter; V Glover; M Sandler; P K Gillman; P K Bridges
Journal:  Clin Chim Acta       Date:  1981-12-24       Impact factor: 3.786

View more
  1 in total

1.  Human liver budesonide sulphotransferase is inhibited by testosterone and correlates with by testosterone sulphotransferase.

Authors:  G M Pacifici; M A Ferroni; A Temellini; A Gucci; M C Morelli; L Giuliani
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.